References
- Parsons SK, Skapek SX, Neufeld EJ, . Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997;89:1886–1895.
- Cohen H, Bielorai B, Harats D, . Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010;54:703–706.
- Hoogerbrugge N, Jansen H, Hoogerbrugge PM. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase acitivity. Leukemia 1997;11:1377–1379.
- Tozuka M, Yamauchi K, Hidaka H, . Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma. Ann Clin Lab Sci 1997;27:351–357.
- Cremer P, Lakomek M, Beck W, . The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukemia. Eur J Pediatr 1988;147:64–67.
- Taskinen MR, Nikkila EA, Pelkonen R, . Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 1983;57:619–626.
- Staels B, van Tol A, Chan L, . Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb 1991; 11:760–769.
- Ridola V, Buonuoma PS, Maurizi P, . Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatr Blood Cancer 2008;50:378–380.
- Kfoury-Baz EM, Nassar RA, Tanios RF, . Plasmapheresis in asparaginase-induced hypertriglyceridemia. Transfusion 2008;48: 1227–1230.
- Nakagawa M, Kimura S, Fujimoto K, . A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis. Ther Apher Dial 2008;12:509–513.
- Kado S, Murakami T, Aoki A, . Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus. Diabetes Res Clin Pract 1998;41:49–55.
- Ogawa S, Takeuchi K, Ito S. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. Diabetes Obes Metab 2004;6:384–390.
- Malaguarnera M, Giugno I, Ruello P, . Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceidaemias. Br J Clin Pharmacol 1999;48:605–609.